Safety and efficacy of autologous non-hematopoietic enriched stem cell nebulization in COVID-19 patients: a randomized clinical trial, Abu Dhabi 2020
Research
[키워드] 95% CI
Abu
adaptive
Administered
Adverse
adverse events
approval
assessments
autologous
caused
Cell
center
Clinical improvement
Clinical outcome
clinical trial
cocktail
Committee
complement
conducted
Control
control group
coronavirus disease
COVID-19
COVID-19 patients
discharge
effective
Efficacy
Emirate
event
exceptional
experimental group
hospital
immunomodulation
improvement
include
institutional review board
Intervention
IRB
mortality rate
Nebulizers and vaporizers
occurred
Open-label
overall survival
pandemic
Patient
patients
Peripheral blood
primary endpoint
Randomized
randomized clinical trial
receiving
Recovery of function
reduce
reduction
reduction in
Registered
released
reported
Result
Safe
Safety
SARS-CoV-2
seven-category ordinal scale
severity
standard care
STEM
stem cells
Symptom
therapy
Treatment
vaccination rates
virus
[DOI] 10.1186/s41231-021-00101-5 PMC 바로가기 [Article Type] Research
[DOI] 10.1186/s41231-021-00101-5 PMC 바로가기 [Article Type] Research